Introduction
Most deaths from prostate cancer are due to metastases that are resistant to therapy (Greenlee et al., 2000) . The pathogenesis of cancer metastasis consists of a series of sequential and selective steps that include tumor cell proliferation, angiogenesis, detachment, invasion, intravasation, survival in the circulation, adhesion to endothelial cells, extravasation, and growth in distant organs (Fidler, 1990) . Numerous reports have demonstrated that in prostate cancer as well as in other tumor types, the metastatic potential of tumor cells directly correlates with the expression level of several angiogenic genes, including vascular endothelial growth factor (VEGF), also called vascular permeability factor (VPF) (Balbay et al., 1999; Duque et al., 1999; Melnyk et al., 1999) ; basic ®broblast growth factor (bFGF) (Nakamoto et al., 1992; Giri et al., 1999; Melnyk et al., 1999) , interleukin-8 (IL-8) and, type IV collagenases (MMP-2 and MMP-9) (Hamdy et al., 1994; Greene et al., 1997; Melnyk et al., 1999; Kuniyasu et al., 2000) .
Many of those molecules function as pro-angiogenic factors. VEGF has been shown to induce the proliferation of endothelial cells, to increase vascular permeability, to increase endothelial cell survival, and to induce the production of plasminogen activator by these cells (Senger et al., 1983; Leung et al., 1989) . IL-8, a chemoattractant cytokine, has been shown to attract and activate neutrophils in in¯ammatory regions, to upregulate expression of MMPs and to directly induce angiogenesis (Koch et al., 1992; Mukaida et al., 1994) . The proteolytic activity of MMP-9, the 92-kd type IV gelatinase/collagenase, facilitates the migration of endothelial cells through the altered extracellular matrix toward the source of the angiogenic stimulus (Hiraoka et al., 1998; Puyraimond et al., 1999) .
How the constitutive expression of these genes is regulated in malignant prostate cancer cells is not clear. Recent studies have demonstrated that the pleiotropic transcription factor NF-kB regulates the expression of multiple genes including IL-8 and MMP-9 in several types of cells (Mukaida et al., 1994; Vilarete et al., 1996; Yokoo and Kitamura, 1996; Bond et al., 1998) . Importantly, NF-kB has been shown to be constitutively activated in prostate cancer cells (Palayoor et al., 1999 , Pajonk et al., 1999 , and elevated NF-kB activity is also sustained in androgen-responsive human prostate cancer cells by androgen treatment (Ripple et al., 1999) .
NF-kB is an inducible dimeric transcription factor that belongs to the Rel/NF-kB family of transcription factors whose prototype in most nonlymphoid cells is a heterodimer composed of the RelA (p65) and NF-kB1 (p50) subunits (Verma et al., 1995; Barnes et al., 1997) . NF-kB activation involves its release from its inhibitor, IkB, and its subsequent translocation from the cytoplasm to the nucleus, where it binds to cognate sequences in the promoter region of multiple genes. Regulation of gene expression by NF-kB is controlled mainly by the inhibitory IkB proteins, which include IkBa (Beg and Baldwin, 1993; Verma et al., 1995; Barnes et al., 1997) . Upon stimulation, IkBa is rapidly phosphorylated and degraded via the ubiquitin-proteasome pathway, permitting activation and nuclear import of NF-kB. Dominant-negative mutant forms of IkBa (IkBaM) have been engineered that cannot be phosphorylated and degraded, and thus the nuclear importation and DNA binding of NF-kB/relA complexes are repressed constitutively in stably transfected as well as in transiently transfected cells (Brockman et al., 1995; Brown et al., 1995; Traenckner et al., 1995; Van Antwerp et al., 1996; Reuther et al., 1998) .
Numerous in vitro and in vivo studies have suggested that NF-kB/relA plays an important role in the regulation of cell proliferation, apoptosis, and adhesion (Higgins et al., 1993; Beg et al., 1996; Gilmore et al., 1996; Van Antwerp et al., 1996; Wang et al., 1996; Reuther et al., 1998; Duey et al., 1999; Yoshida et al., 1999; Huang et al., 2000) . Whether NF-kB/relA also regulates angiogenesis, tumorigenicity, invasion, and metastasis of prostate cancer is not known. In the present study, highly malignant human prostate cancer cells PC-3M constitutively expressed high levels of NFkB/relA activity. Transfection of these cells with IkBaM, which inhibits NF-kB activity (Van Antwerp et al., 1996) , was associated with decreased expression of VEGF, IL-8, and MMP-9 and hence decreased angiogenesis, invasion, and metastasis of human prostate cancer cells growing in the prostate of nude mice.
Results

Downregulation of constitutive NF-kB activity in metastatic human prostate cancer cells by transfection with IkBaM expression vector
In the ®rst set of experiments, highly metastatic PC-3M human prostate adenocarcinoma cells were stably transfected with the IkBaM expression vector, which encodes a mutated IkBa. Western blot analysis detected expression of endogenous IkBa in PC-3M, control pLXSN-transfected (Neo), and IkBaM-transfected (IkBaM.1, IkBaM.2 and IkBaM.3) PC-3M cells, whereas it detected exogenous mutant IkBa only in the IkBaM-transfected PC-3M cells (Figure 1a) .
To determine whether the expression of IkBaM led to a block of nuclear translocation of NF-kB, we probed nuclear extracts of PC-3M, PC-3M-Neo, and IkBaM-transfected PC-3M cells for NF-kB activity by EMSA. Antibodies detecting either the p65 or p50 components of NF-kB were used to con®rm the EMSA was performed as described above. For competition reactions, nuclear protein was extracted from PC-3M-Neo cells, and unlabeled cold wild-type NF-kB (lane 6) or mutant NF-kB (lane 7) oligonucleotide were added to the reaction mixture. For supershift reactions, speci®c anti-p65 (lane 8) and anti-p50 (lane 9) antibodies were added to the reaction mixture. (c) NF-kB-Luc reporter activity. Luciferase reporters driven by either wild-type (2x NF-kB-wt-luc) or mutant (2x NF-kB-mt-luc) NF-kB response elements were cotransfected with pBActin-RL into the dierent prostate cancer cells. Fire¯y and Renilla luciferase activities were quanti®ed using the dual-luciferase reporter assay system. Luciferase activity in test samples was compared with the activity in PC-3M cells transfected with 2x NF-kB-mt-luc, which was assigned the value of 1. Note that IkBaM transfection suppressed NF-kB activities (*P50.01). This is one representative experiment of two speci®city of the EMSA analysis. As shown in Figure  1b , constitutive NF-kB binding activity was present in PC-3M cells. The expression of IkBaM signi®cantly inhibited the NF-kB activity in IkBaM transfected cells (IkBaM.1, IkBaM.2 and IkBaM.3) but not in the control Neo cells. The speci®city of the observed bandshift was checked by supershift experiments with anti-p65 and anti-p50 antibodies, which indicated that the NF-kB complexes contained both p50 and p65 components. Next, we con®rmed the suppressive eect of IkBaM transfection on the constitutive levels of NF-kB/relA activity by using NF-kB-dependent luciferase reporter activity assay. A 2x NF-kB-Luc (wild-type) or a 2x NF-kB-mut-luc (mutant) reporter (DiDonato et al., 1997) was transiently transfected into the PC-3M cells.
As shown in Figure 1c, 
Transfection of PC-3M cells with IkBaM expression vector downregulates expression of proangiogenic molecules
The eect of NF-kB inhibition on the expression of proangiogenic molecules including VEGF, IL-8, and MMP-9 was studied in the IkBaM-transfected PC-3M cells. The data shown in Figure 3a demonstrate that, consistent with a decreased NF-kB promoter activity, VEGF, IL-8, and MMP-9 promoter activities were signi®cantly suppressed in IkBaM-transfected PC-3M cells as compared to parental PC-3M and Neo cells. These results suggest that in addition to IL-8 and MMP-9, NF-kB may directly regulate VEGF expression at the transcriptional level.
The expression of VEGF, IL-8, and MMP-9 genes in IkBaM-transfected cells was further determined at both the mRNA and protein levels. Cellular mRNA was extracted from prostate cancer cells and subjected to Northern blot analysis. As shown in Figure 3b , VEGF, IL-8, and MMP-9 mRNA expression was signi®cantly lower in IkBaM.1, IkBaM.2 and IkBaM.3 cells than in control PC-3M and Neo cells. Consistently, IkBaMtransfected PC-3M cells secreted signi®cantly decreased levels of VEGF and IL-8 into the culture supernatant as determined by quantitative IL-8 and VEGF ELISA ( Figure 3c ).
Suppression of human prostate cell invasion by transfection with IkBaM
Next we analysed whether the expression of MMP-9 in IkBaM-transfected PC-3M cells correlated with their ability to invade through basement membrane. The level of MMP-9 protein levels were measured by zymographic assay of collagenase activity with the volume of culture supernatant normalized for cell number. Densitometric measurements indicated that the 92-Kb MMP-9 collagenase activity of PC-3M- The mice were euthanized 6 weeks later and necropsied. Tumorigenicity (incidence, tumor weight) and lymph node metastasis were recorded. In contrast to PC-3M and PC-3M-Neo cells, PC-3M-IkBaM cells produced small tumors and a low incidence of spontaneous lymph node metastasis (Table 1) . Therefore, inhibition of NFkB activity by IkBaM transfection was associated with suppression of tumorigenicity and metastasis in this androgen-independent prostate cancer system.
Inhibition of NF-kB activation and decreased expression of VEGF, IL-8, and MMP-9 in IkBaM-transfected tumors
Immunohistochemical (IHC) analyses were undertaken to determine whether IkBaM transfection suppressed NF-kB activity in prostate cancer cells growing in the prostate of nude mice. Analysis of tumors using antibodies that recognize the nuclear localization sequence of the activated form of NF-kB p65 demonstrated inhibition of activated NF-kB in the PC-3M-IkBaM tumors ( Figure 5 ). The in vivo protein expression of VEGF, IL-8, and MMP-9 protein was also evaluated by IHC. Signi®cant staining for IL-8, MMP-9, and VEGF was found in untransfected and, Neo-transfected tumors, but not in the IkBaMtransfected tumors. Thus, expression of IkBaM in prostate cancer cells inhibited constitutive activation of Figure 3 Decreased expression of proangiogenic molecules in metastatic human prostate cells transfected with IkBaM expression vector. (a) IL-8, MMP-9, and VEGF promoter activity. pGL2 ± IL-8, pGL2 ± MMP-9 and PGL2 ± VEGF reporters were cotransfected with pB-Actin-RL (Renilla) reporter into the prostate cancer cells. The pGL2-basic luciferase reporter served as negative control. Luciferase activity was determined as described in Figure 1c . The increase in luciferase activity was calculated relative to the luciferase activity of pGL2-basic in PC-3M cells which was assigned the value of 1. (b) Northern blot. Cellular mRNA was extracted and Northern blot analysis was performed using IL-8, VEGF, and MMP-9 cDNA probes. Equal loading of mRNA was monitored by hybridizing the same membrane ®lter with a GAPDH cDNA probe. (c) ELISA. IL-8 and VEGF proteins in the culture supernatants determined by ELISA were expressed as pg/10 6 cells/48 h. Note that IkBaM transfection suppressed IL-8 and VEGF protein production (*P50.01) NF-kB, which was in turn associated with reduced expression of VEGF, IL-8, and MMP-9.
Inhibition of angiogenesis in IkBaM-transfected human prostate cancers
Finally, we determined whether decreased NF-kB/relA activity and VEGF, IL-8, and MMP-9 production correlated with suppression of tumor angiogenesis.
Mean vessel density was determined by IHC using anti-CD31 antibodies ( Figure 5 ). Tumors formed by PC-3M and Neo-transfected cells contained numerous blood vessels, whereas the tumors formed by IkBaMtransfected cells did not.
Discussion
The present results demonstrate that suppression of NF-kB activity in human prostate cancer cells by IkBaM transfection inhibits their tumorigenic and metastatic properties in nude mice by suppressing angiogenesis and invasion. IkBaM transfection-blocked NF-kB activity was associated with down-regulation of VEGF, IL-8, and MMP-9 promoter activities and decreased expression of these genes in cultured cells and in cells implanted into the prostate gland of nude mice. The decreased expression of VEGF, IL-8, and MMP-9 in vivo directly correlated with decreased neovascularization and production of lymph node metastasis. Our results, therefore, provide direct evidence for the involvement of NF-kB in the regulation of angiogenesis and metastasis of prostate cancer cells.
The progressive growth and metastasis of prostate cancers are angiogenesis-dependent. Tumor angiogenesis is mediated, in part, by the secretion of angiogenic factors by tumor cells and host cells (Folkman, 1992; Fidler and Ellis, 1994) . Prostate cancer cells can secrete a variety of proangiogenic molecules, including VEGF, IL-8, and collagenases. Expression of VEGF by prostate cancer cells has been shown to directly correlate with malignant potential (Ferrer et al., 1997; Jackson et al., 1997) , and the administration of anti-VEGF antibodies to mice injected with human prostate cancer cells has been shown to inhibit neovascularization within the tumors (Borgstrom et al., 1998) . Previous studies have shown that serum concentrations of IL-8 associated with increasing prostate cancer stage (Moore et al., 1999; Veltri et al., 1999) . Further IL-8 expression is associated with increased tumorigenicity, angiogenesis, and metastasis of prostate cancer cells (Inoue et al., 2000) . MMP activity also appeared to be 1610 6 ) were injected into the prostate of nude mice. Primary tumors in prostates were weighed, and lymph node metastasis was determined by histology. *P50.001, Mann ± Whitney U-test Prostate cancer and NF-kB S Huang et al increased in malignant prostatic tissue compared with BPH. MMP-9 was shown to be exclusively expressed by malignant human prostate cancers (Hamdy et al., 1994 ) and murine prostate model systems (Sehgal et al., 1998) . The mechanism that is responsible for overexpression of these metastasis-related genes in prostate cancer cells is unknown. Since NF-kB is a pleiotropic transcription factor that controls the expression of many genes, including inducible and constitutive IL-8 (Mukaida et al., 1994; Vilarete and Remick 1996) and MMP-9 (Yokoo and Kitamura, 1996; Bond et al., 1998), we determined whether it regulates the expression of these angiogenic molecules in prostate cancer cells. The signi®cant decrease in activity of VEGF, IL-8, and MMP-9 promoters in the IkBaM-transfected cells suggested that NF-kB regulates constitutive expression of these genes in PC-3M cells, at least in part, at the transcription level. Our data agree with previous reports that both IL-8 and MMP-9 promoters contain NF-kB binding elements (Matsusaka et al., 1993; Sato et al., 1993) . The human VEGF promoter was shown to contain multiple binding sites for Sp-1, AP-1, and AP-2 transcription factors and hypoxia-regulated elements (Garrido et al., 1993; Levy et al., 1995) . More recently, it has been shown that induction of VEGF in UV-irradiated skin cells can be blocked by treatment with NF-kB decoy oligodeoxynucleotides (Abeyama et al., 2000) , suggesting that NF-kB could play a role in the regulation of VEGF expression. Our ®nding that constitutive VEGF expression is downregulated by blocking NF-kB activity in human prostate cells supports this concept. Studies are under way to de®ne the NF-kB binding sites in the 5'-and/or 3'-regulatory region(s) of the VEGF gene.
MMP-9 and one of its indirect activators, uPA, are critical elements for the intravasation of tumor cells (Kim et al., 1998) . The local production of MMP-9 by prostate cancer or stroma facilitates the local degradation of the extracellular matrix and results in tumor invasion and subsequent metastasis (Ray and StetlerStevenson, 1994) . In the present study, we found that IkBaM transfection, which blocked NF-kB activity, inhibited the expression of MMP-9 by PC-3M cells, resulting in decreased invasion through basement membrane.
Although our data clearly showed that blocking NFkB activity suppressed tumor growth and metastasis of human prostate cancer by inhibiting of angiogenesis and invasion, we cannot exclude contributions from other mechanisms. For example, it has been shown that blocking NF-kB results in inhibiting cell adhesion (Higgins et al., 1993) and induces production of proin¯ammatory cytokines (Duey et al., 1999) and Figure 5 Inhibition of activity of NF-kB and decreased expression of VEGF, IL-8, and MMP-9 and vessel formation in PC-3M IkBaM transfectant tumors, as demonstrated by immunohistochemistry of human prostate cancers growing in the prostate of nude mice. PC-3M, PC-3M-Neo, PC-3M ± IkBaM.1, PC-3M ± IkBaM.2, and PC-3M ± IkBaM.3 cells were injected into the prostate of groups of nude mice. Forty-®ve days later, the mice were killed and necropsied. Prostate tumors of similar size were processed for immunohistochemical analysis. Blood vessels were counted using a light microscope after immunostaining of tissue sections with anti-CD31 antibodies. NF-kB (p65), VEGF, MMP-9, and IL-8 immunostaining was performed as described in Materials and methods. Note that tumors formed by IkBaM-transfected cells expressed lower levels of activated NF-kB, MMP-9, VEGF, and IL-8 and were less vascularized than tumors produced by PC-3M or Neo-transfected cells plasminogen activator uPA . NF-kB activation is also involved in the regulation of cell proliferation and apoptosis (Van Antwerp et al., 1996; Beg and Baltimore, 1996; Wang et al., 1996) . Our studies, however, are consistent with previous reports showing that inhibition of NF-kB in cancer cells by stable transfection of IkBaM does not inhibit cell growth (Bentires-Alj et al., 1999; Pajonk, 1999) , and hence the decrease in tumorigenicity was probably due to inhibition of angiogenesis.
The present results extend our previous report that in metastatic human melanoma cells blocking NF-kB activity decreases angiogenesis and metastasis of human melanoma cells (Huang et al., 2000) . Many dierent neoplasms have been shown to express high levels of NF-kB/relA (Gilmore et al., 1996; Nakshatri et al., 1997; Dong et al., 1999; Meyskens et al., 1999; , as do androgen-independent human prostate cells (Pajonk et al., 1999; Palayoor et al., 1999) , and NF-kB activity can be induced by androgen in androgen-sensitive prostate cells (Ripple et al., 1999) . Moreover, many cytokines, present in the prostate cancer microenvironment can activate NF-kB (Barnes and Karin, 1997) . NF-kB activation in prostate cancer may provide a growth advantage by increasing angiogenesis and invasiveness as well as by suppressing apoptosis.
Materials and methods
Cell lines and reagents
PC-3M human prostate carcinoma cells (Stephenson et al., 1992) were maintained in culture (5% CO 2 and 95% air at 378C) as adherent monolayers in minimal essential medium (MEM) supplemented with 10% fetal bovine serum (FBS), sodium pyruvate, nonessential amino acids, L-glutamine, and vitamin solution (Flow Laboratories, Rockville, MD, USA). All cultures were free of mycoplasma and pathogenic murine viruses. All reagents used in tissue culture were free of endotoxins as determined by the Limulus amebocyte lysate assay (sensitivity limit of 0.125 ng/ml) purchased from Associates of Cape Cod (Falmouth, MA, USA).
Animals
Male athymic BALB/c nude mice were purchased from the Animal Production Area of the National Cancer Institute, Frederick Cancer Research Facility (Frederick, MD, USA). The mice were housed in laminar¯ow cabinets under speci®c pathogen-free conditions and used at 10 weeks of age. Animals were maintained according to institutional regulations in facilities approved by the American Association for Accreditation of Laboratory Animal Care in accordance with current regulations and standards of the United States Department of Agriculture, Department of Health and Human Services, and National Institutes of Health.
ELISA for human IL-8 and VEGF expression
The level of IL-8 and VEGF protein in culture supernatants was determined by using a quantitative immunometric sandwich enzyme immunoassay (ELISA) kit (Quantikine IL-8 and VEGF ELISA kits, R&D Systems, Minneapolis, MN, USA). The absorbance of the samples was compared with the standard curve (Huang et al., 2000) .
Northern blot analysis
Cellular mRNA was extracted from prostate cancer cells by using the FastTrack mRNA isolation kit (Invitrogen Co., San Diego, CA, USA). The mRNA (2 mg) was separated electrophoretically on 1% denaturing formaldehyde agarose gel, transferred to a GeneScreen nylon membrane (DuPont Co., Boston, MA, USA) in 206 standard saline citrate, and cross-linked with a UV-Stratalinker 1800 (Stratagene, La Jolla, CA, USA). The cDNA probe used in the analysis was a 0.5-kb EcoRI cDNA fragment corresponding to human IL-8, a 1.0-kb cDNA fragment corresponding to human MMP-9 (Inoue et al., 2000) , and a 0.204-kb BamHI/EcoRI cDNA fragment corresponding to human vascular endothelial growth factor (VEGF/VPF) (Balbay et al., 1999) . The cDNA probes were labeled with 32 P-deoxycytidine triphosphate using a random labeling kit (Roche, Indianapolis, IN, USA). The equivalence of mRNA sample loading was monitored by hybridizing the same membrane ®lter with a GAPDH cDNA probe.
Promoter reporters and dual luciferase assays
Luciferase reporters driven by either two-copy wild-type (2x NF-kB-Luc) or mutant (2x NF-kB-mt-Luc) NF-kB responsive elements (DiDonato et al., 1997) were used in this study. pGL2-IL8 is a pGL2-basic reporter containing a full-length ®re¯y luciferase gene under the control of an IL-8 promoter anking region from +44 to 71481 from pxp2-IL8 (Mukaida et al., 1994) . pGL2-MMP-9 is a pGL2-basic reporter containing a full-length ®re¯y luciferase gene under the control of MMP-9 5'-¯anking region from +53 to 7670 (Gum et al., 1997) . The pGL2-VEGF is a pGL2-basic reporter containing a full-length ®re¯y luciferase gene under the control of both a VEGF 5'-¯anking region from +50 to 72274 and a 3'-UTR region from +1 to +1921 (Tischer et al., 1991) . Prostate cancer cells (1610 5 /well) growing in 6-well tissue culture plates were transfected with the indicated reporter plasmids using the Lipofectin reagent (Life Technologies, Inc., Gaithersburg, MD, USA). Transfection eciency was normalized by cotransfection with a pBActin-RL reporter containing a full-length renilla luciferase gene (Promega, Madison, WI, USA) under the control of a human b-actin promoter (Huang et al., 1998) . Forty-eight hours after transfection, the cells were harvested in passive lysis buer (Promega Corp., Madison, WI, USA). Fire¯y luciferase and renilla luciferase activities were quanti®ed using the dual luciferase assay system (Promega). Changes in luciferase activity were calculated relative to the luciferase activity of pGL2-basic in PC3-M cells, which was given the reference value of 1 as described (Huang et al., 1998) .
Stable transfection of prostate cancer cells with IkBaM and control vector
The cDNA plasmid pLXSN ± IkBaM contains mutations at S32 and S36 of the NH 2 -terminus and a COOH-terminal PEST sequence mutation (Van Antwerp et al., 1996) . PC-3M cells (1610 6 ) were transfected using 15 ml of lipofectin reagent (Life Technologies, Inc., Gaithersburg, MD, USA) and 4 mg of pLXSN ± IkBaM expression vector or control pLXSN vector. Transfections were carried out according to the manufacturer's instructions. Cells were selected with Prostate cancer and NF-kB S Huang et al standard medium containing 600 mg/ml G418. Fourteen days later, neo-resistant colonies were isolated by trypsinization and established as subcultures.
Western blot analysis
Cytosolic protein was isolated from control and transfected prostate cancer cells. The soluble protein was separated on 10% SDS ± PAGE by electrophoresis and electrophoretically transferred onto Immobilon-P transfer membrane (Millipore, Bedford, MA, USA). The endogenous and mutant IkBa were probed with a polyclonal rabbit anti-human and anti-mouse IkBa (C-21, Santa Cruz Biotechnology, Santa Cruz, CA, USA). The probe proteins were detected with the Amersham ECL system according to the manufacturer's instructions.
Electrophoretic mobility gel shift assay (EMSA)
Nuclear protein extracts were prepared as described before (Huang et al., 1998) . The NF-kB oligonucleotide probe was 5'-AGTTGAGGGACTTTCCCAGGC-3'. EMSA was performed as described previously with minor modi®cations (Huang et al., 1998) . Five micrograms of nuclear extract protein and 30 000 c.p.m. of end-labeled double-stranded DNA probe were added to the mixture. The binding reaction was allowed to proceed for 25 min at 228C. For supershift reactions, extracts were preincubated with anti-p65 or antip50 antibody (Calbiochem, San Diego, CA, USA) for 20 min on ice. For competition reaction using unlabeled wild-type NF-kB (wtkB) or mutant NF-kB (mkB) probes, nuclear extracts were incubated with 50-fold molar excess of unlabeled probes before the addition of the labeled probes.
Orthotopic implantation of tumor cells
Cultured PC-3M, PC-3M-neo, and IkBM-transfected cells were prepared for injection as described previously (Stephenson et al., 1992) . Mice were anesthetized with Nembutal and placed in the supine position. A lower-midline incision was made, and viable tumor cells (5610 5 /40 ml) in HBSS were implanted into the dosal prostate lobes using a 30-gauge needle with a 1-ml disposable syringe and a calibrated, push button-controlled dispensing device (Hamilton Syringe Co., Reno, NV, USA). The prostate was returned to the abdominal cavity, and the abdominal wall was closed with a single layer of metal wound clips. Mice were killed 45 days after the intraprostatic implantation of tumor cells. The primary tumors were resected and weighed. Regional lymph node metastasis was assessed by microscopic examination of H&E-stained formalin-®xed paran-embedded tissues.
Immunohistochemistry and quantitation of microvessel density
Prostate tumors harvested at autopsy were processed for immunostaining using anti-NF-kB (p65) (Boehringer Mannheim, Indianapolis, IN, USA), anti-IL-8 (Biosource International, Camarillo, CA, USA), anti-VEGF (Santa Cruz Biotechnology), anti-MMP-9 (Oncogene Research Products, Cambridge, MA, USA), and anti-CD31/PECAM-1 (Pharmingen, San Diego, CA, USA) antibodies and appropriate peroxidase-conjugated secondary antibodies. The slides were examined under a bright-®eld microscope. A positive reaction was indicated by a reddish-brown precipitate in the cytoplasm. Negative controls were done using nonspeci®c IgG. Microvessel density of tumor was analysed by anti-CD31 immunostaining. Images were digitized using a Sony 3CD color video camera (Sony Corp., Tokyo, Japan) and a personal computer equipped with Optimas Image Analysis Software (Optimas Corp., Bothell, WA, USA).
Collagenase activity
Cells (5610 4 ) were seeded in six-well plates and grown to 60 ± 70% con¯uence. The cells were washed with HBSS twice and grown for 24 h in serum-free medium. The supernatant was collected for collagenase activity, and the remaining cells were counted to con®rm the cell number. Collected samples were concentrated 50-fold using a Microcon microconcentrator (Amicon, Inc., Beverly, MA, USA). The samples were separated on 10% SDS-polyacrylamide gel containing 1 mg/ml gelatin (Sigma) by electrophoresis. After electrophoresis, the gel was washed at room temperature for 30 min in wash buer (50 mM Tris-Cl, pH 7.5, 15 mM CaCl 2 1 mM ZNCl 2 , 2.5% Triton X-100) and incubated 24 h at 378C with shaking in the same buer except for a 1% concentration of Triton X-100. The gel was stained with a solution of 0.1% Coomassie brilliant blue R-250. Clear zones against the blue background indicated the presence of gelatinolytic activity.
Matrigel-coated filter-invasion assay
Polyinylprolidone-free polycarbonate ®lters (8 mm pore size; Nucleopore; Becton Dickinson Labware, Franklin Lakes, NJ, USA) were coated with a mixture of basement membrane components (Matrigel, 50 mg/®lter) and placed in modi®ed Boyden chambers. The tumor cells (1610 5 ) were seeded in the upper compartment of the Boyden chamber with MEM containing 0.1% BSA for 6 h at 378C. NIH3T3 ®broblast-conditioned medium in the lower compartment served as a chemoattractant. The cells that migrated to the lower surface of the ®lter were stained with Di-Quick (American Scienti®c Products, McGraw Park, IL, USA). Cells were counted at a 4006magni®cation, and the mean numbers of cells per ®eld in 10 random ®elds were recorded. Duplicate ®lters were used. The experiments were carried out three times.
Statistical analysis
The signi®cance of the in vitro results was determined by the Student's t-test (two-tailed); the signi®cance of the in vivo metastasis results was determined by the Mann ± Whitney Utest.
